Recent News

• 05.14.2026 - Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
• 03.19.2026 - Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update
• 03.19.2026 - Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update
• 02.17.2026 - Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference

Recent Filings

• 05.06.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.28.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.10.2026 - 3 Initial statement of beneficial ownership of securities
• 04.10.2026 - 3 Initial statement of beneficial ownership of securities
• 04.10.2026 - 3 Initial statement of beneficial ownership of securities
• 04.10.2026 - 3 Initial statement of beneficial ownership of securities
• 04.10.2026 - 3 Initial statement of beneficial ownership of securities
• 04.10.2026 - 3 Initial statement of beneficial ownership of securities
• 03.31.2026 - 3 Initial statement of beneficial ownership of securities
• 03.31.2026 - 3 Initial statement of beneficial ownership of securities